Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MIRIA

Financiado

Cerrado

DEVELOPMENT OF ANTIMICROBIAL, ANTIVIRAL, AND ANTIFUNGAL NANOCOATINGS FOR EVERYDA...

DEVELOPMENT OF ANTIMICROBIAL, ANTIVIRAL, AND ANTIFUNGAL NANOCOATINGS FOR EVERYDAY SURFACES Since the end of 2019, the spread of COVID has deeply changed our lifestyle, resulting in historical events and decisions, such as the EU block of non-essential travel among countries (COMM (2020) 499), affecting the whole EU soci... ver más

31/05/2026

CSM SPA

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

RINA CONSULTING CENTRO SVILUPPO MATERIALI SP... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-06-01

HORIZON-CL4-2021-RESILIENCE-01-31: European Technological and Social I... ExpectedOutcome:Projects are expected to contribute to the following outcomes:

I+D

Cerrada hace 3 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

CSM SPA

Lider

Proyectos interesantes

NANO-PROTECT

Nanotechnology

Medical Technol...

165K€ Cerrado

PHOTO-IASIS

Medical Technol...

Nanotechnology

192K€ Cerrado

PRE2020-093041

Medical Technol...

Nanotechnology

99K€ Cerrado

SONO-textile

Medical Technol...

Nanotechnology

71K€ Cerrado

PID2020-114347RB-C31

Nanotechnology

Medical Technol...

133K€ Cerrado

PID2020-114347RB-C32

Nanotechnology

Medical Technol...

125K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 47 meses Fecha Inicio: 2022-06-01
Fecha Fin: 2026-05-31

Líder del proyecto

RINA CONSULTING CENTRO SVILUPPO MATERIALI SP... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Since the end of 2019, the spread of COVID has deeply changed our lifestyle, resulting in historical events and decisions, such as the EU block of non-essential travel among countries (COMM (2020) 499), affecting the whole EU society economically and psychologically. However, as reported in the HERA target priorities, the persistence of the emergency status requires daily actions that tackle the spread of COVID.In this economical, societal and clinical context, the project MIRIA aims to develop wide-range-antimicrobial nanocoatings to be used in hospitals and other environments where cross-contamination and contagion risk are significant issues. In the wake of the covid outbreak, there has been large concern about infection spread of pathogens (i.e., bacteria, fungi, virus, and specifically SARS-CoV-2) via high traffic surfaces (i.e., medical equipment). State of the art and commercial products coating solutions that both target a range of mixed pathogens and different surfaces (e.g., glass, metal, textile) are unfortunately scant. MIRIA solutions aim to fill this void, impacting on EU health, both directly (by creating public safe environments) and indirectly (by reducing COVID spreading and decreasing ill-related work absences and psychological pathologies). A reduction of the work absence of at least 5% with respect to the 2020 value (15M in EU) is expected.MIRIA main challenging ambition is to develop nanocoatings with a 99.99% effectiveness against a wide range of pathogens, especially SARS-CoV-2. This will be based on a four pieces puzzle: the knowledge in anti-microbial materials, nanopowders, nanocoating and pilot plant conduction. These nanocoatings will be brought to pilot scale (TRL6) and, within 3 years after the end of the project, they are foreseen to enter the market (TRL9). The exploitation of MIRIA outputs deeply involves SMEs and the dissemination plan will follow a spill-over strategy in order to involve public and private stakeholders.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores